Company: SXI
Filing Date: 2025-08-04
Form Type: 10-K
Source: 0001437749-25-024450
Chunk: 592

Company: STANDEX INTERNATIONAL CORP/DE/
Filing Date: 2025-08-04
Form: 10-K
Item: Item 7
Chunk 592
---
 synergies between the acquisition and existing operations of the Company are considered organic growth for the purposes of our discussion.

Unless otherwise noted, references to years are to fiscal years.

Consolidated Results from Continuing Operations (in thousands):

      2025 

      2024 

      2023 

      Net sales 
      
     $
     790,107

     $
     720,635

     $
     741,048

      Gross profit margin 

     39.9
     %

     39.1
     %

     38.5%

      Restructuring costs 

     6,903

     8,206

     3,831

      Acquisition related expenses 

     21,434

     2,622

     557

      Other operating (income) expense, net 

     -

     110

     (611)

      (Gain) loss on sale of business 

     -

     (274
     )

     (62,105)

      Income from operations 

     93,549

     101,738

     171,089

      Backlog (realizable within 1 year) 
      
     $
     245,596

     $
     185,296

     $
     274,902

      2025 

      2024 

      2023 

      Net sales 
      
     $
     790,107

     $
     720,635

     $
     741,048

      Components of change in sales: 

      Effect of acquisitions 

     123,636

     40,427

     1,919

      Effect of exchange rates 

     (343
     )

     (1,842
     )

     (23,902)

      Effect of business divestitures 

     -

     (21,259
     )

     (11,947)

      Organic sales change 

     (53,821
     )

     (37,739
     )

     39,639

Net sales increased for fiscal year 2025 by $69.5 million, or 9.6% when compared to the prior year period. Acquisitions accounted for increased sales of $123.6 million, or 17.2%. Organic sales decreased by $53.8 million, or 7.5%, due to general economic softness in Europe and North America in the Electronics segment, the impact of National Institutes of Health